Subscribe To
Windtree Announces Istaroxime Scientific Abstract Has Been Accepted at the 2023 Technology and Heart Failure Therapeutics Conference
WARRINGTON, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, is targeting cardiogenic shock as a potential indication for its drug candidate, istaroxime. The Company announced that its abstract entitled “Safety and Efficacy of Istaroxime 1.0 […] The post Windtree Announces Istaroxime Scientific Abstract Has Been Accepted at the 20...
Read More
Content Topics
Windtree
Announces
Istaroxime
Scientific
Abstract
Been
Accepted
Technology
Failure
Therapeutics
Conference
Forex
Posted: Feb 27 2023, 13:00
Author Name: forextv
Views: 082257